BioMark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was CAD 0.019818 million. Net loss was CAD 0.724031 million compared to CAD 0.510213 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.184 EUR | +1.66% | +6.36% | +25.17% |
1st Jan change | Capi. | |
---|---|---|
+25.17% | 17.62M | |
-20.45% | 10.67B | |
+43.17% | 3.22B | |
-35.86% | 2.09B | |
-17.21% | 2.04B | |
-29.81% | 1.46B | |
+17.56% | 1B | |
-4.37% | 734M | |
-37.00% | 391M | |
-46.94% | 379M |